Organizational factors associated with the use of contingency management in publicly funded substance abuse treatment centers

Journal of Substance Abuse Treatment

Volumn 40, Issue 1, 2011, Pages 87-94

  Bride, Brian E ^a   Abraham, Amanda J ^a   Roman, Paul M ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Adoption of innovations; Contingency management; Motivational incentives; Organizational factors

Indexed keywords

ARTICLE; BEHAVIOR MODIFICATION; BEHAVIOR THERAPY; CLINICAL PRACTICE; CONTINGENCY MANAGEMENT; DRUG DEPENDENCE TREATMENT; HEALTH CARE FINANCING; HEALTH CARE MANAGEMENT; HEALTH CARE ORGANIZATION; HEALTH CENTER; HEALTH PROGRAM; OUTPATIENT CARE; PRIORITY JOURNAL; SUBSTANCE ABUSE; UNITED STATES;

ACCREDITATION; BEHAVIOR THERAPY; CONDITIONING, OPERANT; FINANCIAL MANAGEMENT; HUMANS; ORGANIZATIONAL CULTURE; ORGANIZATIONAL INNOVATION; OWNERSHIP; PATIENTS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS;

EID: 78649801384     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2010.08.001     Document Type: Article

References (54)

1. Abraham A.J., Knudsen H.K., Rothrauff T.C., Roman P.M. The adoption of alcohol pharmacotherapies in the Clinical Trials Network: The influence of research network participation. Journal of Substance Abuse Treatment 2010, 28:275-283.
2. Abraham A.J., Roman P.M. Early adoption of injectable naltrexone for alcohol-use disorders: Findings in the private-treatment sector. Journal of Studies on Alcohol and Drugs 2010, 71:460-466.
3. Amass L., Kamien J. A tale of two cities: Financing two voucher programs for substance abusers through community donations. Experimental and Clinical Psychopharmacology 2004, 12:147-155.
4. Backer T.E., Liberman R.P., Kuehnel T.G. Dissemination and adoption of innovative psychosocial interventions. Journal of Consulting and Clinical Psychology 1986, 54:111-118.
5. Ball S., Bachrach K., DeCarlo J., Farentinos C., Keen M., McSherry T., et al. Characteristics, belief, and practices of community clinicians trained to provide manual-guided therapy for substance abusers. Journal of Substance Abuse Treatment 2002, 23:309-318.
6. Bride B.E., Abraham A.J., Roman P.M. Diffusion of contingency management and attitudes regarding its effectiveness and acceptability. Substance Abuse 2010, 31:127-135.
7. Bride B.E., Humble M.N. Increasing retention of African-American women on welfare in outpatient substance user treatment using low-magnitude incentives. Substance Use & Misuse 2008, 43:1016-1026.
8. Cohen W.M., Levinthal D.A. Absorptive capacity: A new perspective on learning and innovation. Administrative Science Quarterly 1990, 35:128-152.
9. Corby E.A., Roll J.M., Ledgerwood D.M., Schuster C.R. Contingency management interventions for treating the substance abuse of adolescents: A feasibility study. Experimental and Clinical Psychopharmacology 2000, 8:371-376.
10. Damanpour F. Organizational innovation: A meta-analysis of effects of determinants and moderators. Academy of Management Journal 1991, 34:555-590.
11. Damanpour F., Schneider M. Phases of the adoption of innovation in organizations: Effects of environment, organization, and top managers. British Journal of Management 2006, 17:215-236.
12. Ducharme, L. J., Knudsen, H. K., Abraham, A. J., & Roman, P. M. (in press). Counselor attitudes toward the use of contingency management in addiction treatment. American Journal on Addiction.
13. Ducharme L.J., Knudsen H.K., Roman P.M. Availability of integrated care for co- occurring substance abuse and psychiatric conditions. Community Mental Health Journal 2006, 42:363-375.
14. Ducharme L.J., Knudsen H.K., Roman P.R., Johnson J.A. Innovation adoption in substance abuse treatment: Exposure, trialability, and the Clinical Trials Network. Journal of Substance Abuse Treatment 2007, 32:321-329.
15. Friedmann P.D., Alexander J.A., Jin L., D'Aunno T.A. On-site primary care and mental health services in outpatient drug abuse treatment units. Journal of Behavioral Health Services & Research 1999, 26:80-94.
16. Friedmann P.D., Taxman F.S., Henderson C.E. Evidence-based treatment practices for drug-involved adults in the criminal justice system. Journal of Substance Abuse Treatment 2007, 32:267-277.
17. Fuller B.E., Rieckmann T., McCarty D., Smith K.W., Levine H. Adoption of naltrexone to treat alcohol dependence. Journal of Substance Abuse Treatment 2005, 28:273-280.
18. Griffith J.D., Rowan-Szal G.A., Roark R.R., Simpson D.D. Contingency management in outpatient methadone treatment: A meta-analysis. Drug and Alcohol Dependence 1999, 58:55-66.
19. Herbeck D.M., Hser Y., Teruya C. Empirically supported substance abuse treatment approaches: A survey of treatment providers' perspectives and practices. Addictive Behaviors 2008, 33:699-712.
20. Institute of Medicine Bridging the gap between practice and research: Forging partnerships with community-based drug and alcohol treatment 1998, National Academy Press, Washington, DC.
21. Kamon J., Budney A., Stanger C. A contingency management intervention for adolescent marijuana abuse and conduct problems. Journal of the American Academy of Child and Adolescent Psychiatry 2005, 44:513-521.
22. Kirby K.C., Benishek L.A., Dugosh K.L., Kerwin M.E. Substance abuse treatment providers' beliefs and objections regarding contingency management: Implications for dissemination. Drug and Alcohol Dependence 2006, 85:19-27.
23. Knudsen H.K., Ducharme L.J., Roman P.M. Early adoption of buprenorphine in substance abuse treatment centers: Data from the private and public sectors. Journal of Substance Abuse Treatment 2006, 30:363-373.
24. Knudsen H.K., Roman P.M. Modeling the use of innovations in private treatment organizations: The role of absorptive capacity. Journal of Substance Abuse Treatment 2004, 26:353-361.
25. Knudsen H.K., Roman P.M., Ducharme L.J., Johnson J.A. Organizational predictors of pharmacological innovation adoption: The case of disulfiram. Journal of Drug Issues 2005, 35:553-568.
26. Lussier J.P., Heil S.H., Mongeon J.A., Badger G.J., Higgins S.T. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 2006, 101:192-203.
27. Marinelli-Casey P., Domier C.P., Rawson R.A. The gap between research and practice in substance abuse treatment. Psychiatric Services 2002, 53:984-987.
28. Mark T.L., Kranzler H.R., Poole V.H., Hagen C.A., McLeod C., Crosse S. Barriers to the use of medications to treat alcoholism. The American Journal on Addictions 2003, 12:281-294.
29. McGovern M.P., Fox T.S., Xie H., Drake R.E. A survey of clinical practices and readiness to adopt evidence-based practices: Dissemination research in the addiction treatment system. Journal of Substance Abuse Treatment 2004, 26:305-312.
30. McKelvey R.D., Zavoina W. Statistical-model for analysis of ordinal level dependent variables. Journal of Mathematical Sociology 1975, 4:103-120.
31. Mee-Lee D.L., Gartner L., Shulman G., Wilford B. Patient placement criteria for the treatment of substance-related disorders 1998, American Society of Addiction Medicine, Chevy Chase, MD. 2nd Ed.
32. Miller W.R., Brown J.M., Simpson T.L., Handmaker N.S., Bien T.H., Luckie L.F., Montgomery H.A., Hester R.K., Tonigan J.S. What works? A methodological analysis of the alcohol treatment outcome literature. Handbook of alcoholism treatment approaches: Effective alternatives 1995, 12-44. Simon & Schuster, Needham Heights, MA. R.K. Hester, W.R. Miller (Eds.).
33. Nelson T.D., Steele R.G. Predictors of practitioner self-reported use of evidence-based practices: Practitioner training, clinical setting, and attitudes toward research. Administration and Policy in Mental Health and Mental Health Services Research 2007, 34:319-330.
34. Oser C.B., Roman P.M. Organizational-level predictors of adoption across time: Naltrexone in private treatment centers. Journal of Studies on Alcohol and Drugs 2007, 68:852-861.
35. Oser C.B., Roman P.M. A categorical typology of naltrexone-adopting private substance abuse centers. Journal of Substance Abuse Treatment 2008, 34:433-442.
36. Petry N.M., Martin B., Cooney J.L., Krantzler H.R. Give them prizes, and they will come: Contingency management for treatment of alcohol dependence. Journal of Consulting and Clinical Psychology 2000, 68:250-257.
37. Petry N.M., Martin B. Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients. Journal of Consulting and Clinical Psychology 2002, 70:398-405.
38. Petry N.M., Peirce J.M., Stitzer M.L., Blaine J., Roll J.M., Cohen A., et al. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: A national drug abuse treatment Clinical Trials Network study. Archives of General Psychiatry 2005, 62:1148-1156.
39. Petry N.M., Simcic F. Recent advances in the dissemination of contingency management techniques: Clinical and research perspectives. Journal of Substance Abuse Treatment 2002, 23:81-86.
40. Petry N.M., Tedford J., Austin M., Nich C., Carroll K., Rounsaville B.J. Prize reinforcement contingency management for treating cocaine users: How low can we go, and with whom?. Addiction 2004, 99:349-360.
41. Prendergast M., Podus D., Finey J., Roll J. Contingency management for treatment of substance use disorders: A meta-analysis. Addiction 2006, 101:1546-1560.
42. Prendergast M.L., Hall E.A., Roll J., Warda U. Use of vouchers to reinforce abstinence and positive behaviors among clients in a drug court treatment program. Journal of Substance Abuse Treatment 2008, 35:125-136.
43. Rash C.J., Alessi S.M., Petry N.M. Contingency management is efficacious for cocaine abusers with prior treatment attempts. Experimental and Clinical Psychopharmacology 2008, 16:547-554.
44. Read J.P., Kahler C.W., Stevenson J.F. Bridging the gap between alcoholism treatment research and practice: Identifying what works and why. Professional Psychiatry; Research and Practice 2001, 32:227-238.
45. Rodgers J.H., Barnett P.G. Two separate tracks? A national multivariate analysis of differences between public and private substance abuse treatment programs. American Journal of Drug and Alcohol Abuse 2000, 26:429-442.
46. Rogers E.M. Diffusion of innovations 2003, Free Press, New York. 5th ed.
47. Roll J.M., Petry N.M., Stitzer M.L., Brecht M.L., Peirce J.M., McCann M.J., Blaine J., MacDonald M., DiMaria J., Lucero L., Kellogg S. Contingency management for the treatment of methamphetamine use disorders. American Journal of Psychiatry 2006, 163:1993-1999.
48. Roman P.M., Johnson A.J. Adoption and implementation of new technologies in substance abuse treatment. Journal of Substance Abuse Treatment 2002, 22:1-8.
49. Simpson D.D. A conceptual framework for transferring research to practice. Journal of Substance Abuse Treatment 2002, 22:171-182.
50. Silverman K., Chutuape M.A., Bigelow G.E., Stitzer M.L. Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: Effects of reinforcement magnitude. Psychopharmacology 1999, 146:128-138.
51. Silverman K., Wong C.J., Higgins S.T., Brooner R.K., Montoya I.D., Contoreggi C., UmbrichtSchneiter A., Schuster C.R., Preston K.L. Increasing opiate abstinence through voucher-based reinforcement therapy. Drug and Alcohol Dependence 1996, 41:157-165.
52. StataCorp Stata Statistical Software: version 10 2007, StataCorp LP, College Station, TX.
53. Willenbring M.L., Kivlahan D., Kenny M., Grillo M., Hagedorn H., Postier A. Beliefs about evidence based practices in addiction treatment: A survey of veterans administration program leaders. Journal of Substance Abuse Treatment 2004, 26:79-85.
54. Yahr H.T. A national comparison of public- and private-sector alcoholism treatment delivery system characteristics. Journal of Studies on Alcohol 1986, 49:233-239.